Timothy R. Carroll

495 citations

15 papers · 433 indexed · h-index 9

Co-authors: David S. Edwards Stuart J. Heminway John Barrett Richard Looby Shuang Liu Anthony R. Harris Milind Rajopadhye Joel Lazewatsky
Topics: Radiopharmaceutical Chemistry and Applications (7 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Peptidase Inhibition and Analysis (3 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Immunology and Allergy Oncology
Journals: Biochemical and Biophysical Research Communications Journal of Medicinal Chemistry Bioconjugate Chemistry
Partner nations: United States Italy Canada

In The Last Decade

Timothy R. Carroll

15 papers receiving 418 citations

Peers

Countries citing papers authored by Timothy R. Carroll

Since Specialization

Citations

This map shows the geographic impact of Timothy R. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy R. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy R. Carroll more than expected).

Fields of papers citing papers by Timothy R. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy R. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy R. Carroll. The network helps show where Timothy R. Carroll may publish in the future.

Co-authorship network of co-authors of Timothy R. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy R. Carroll. A scholar is included among the top collaborators of Timothy R. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy R. Carroll. Timothy R. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The effect of selected preparation variables on the radiochemical purity of 99mTc-sestamibi. 2005 ·PubMed ·Jeffrey P. Norenberg,(unknown),(unknown),Dorothy R. Pathak,Jan Born,Tamara L. Anderson,Timothy R. Carroll	8
2	Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis 1998 ·Behavioural Pharmacology ·Shaker A. Mousa,(unknown),Scott Edwards,Timothy R. Carroll,John Barrett	3
3	New and Versatile Ternary Ligand System for Technetium Radiopharma-ceuticals: Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antago-nist with ^99mTc 1998 ·Bioconjugate Chemistry ·David S. Edwards,Shuang Liu,John Barrett,Anthony R. Harris,Richard Looby,(unknown),Stuart J. Heminway,Timothy R. Carroll	2
4	Biological Evaluation of Thrombus Imaging Agents Utilizing Water Soluble Phosphines and Tricine as Coligands When Used To Label a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc 1997 ·Bioconjugate Chemistry ·John Barrett,(unknown),(unknown),Stuart J. Heminway,Shuang Liu,David S. Edwards,Joel Lazewatsky,Mikhail Kagan,(unknown),Timothy R. Carroll	53
5	New and Versatile Ternary Ligand System for Technetium Radiopharmaceuticals: Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc 1997 ·Bioconjugate Chemistry ·David S. Edwards,Shuang Liu,John Barrett,Anthony R. Harris,Richard Looby,(unknown),Stuart J. Heminway,Timothy R. Carroll	99
6	Synthesis, evaluation and Tc-99m complexation of a hydrazinonicotinyl conjugate of a GP IIb/IIIa antagonist cyclic peptide for the detection of deep vein thrombosis 1997 ·Bioorganic & Medicinal Chemistry Letters ·Milind Rajopadhye,Thomas D. Harris,(unknown),Danuta Głowacka,(unknown),John Barrett,Stuart J. Heminway,David S. Edwards,Timothy R. Carroll	16
7	Labeling a Hydrazino Nicotinamide-Modified Cyclic IIb/IIIa Receptor Antagonist with ^99mTc Using Aminocarboxylates as Coligands 1996 ·Bioconjugate Chemistry ·Shuang Liu,David S. Edwards,Richard Looby,Anthony R. Harris,(unknown),John Barrett,Stuart J. Heminway,Timothy R. Carroll	98
8	Synthesis and technetium-99m labeling of cyclic GP IIb/IIIa receptor antagonists conjugated to 4,5-bis(mercaptoacetamido)-pentanoic acid (mapt) 1996 ·Bioorganic & Medicinal Chemistry Letters ·Milind Rajopadhye,David S. Edwards,(unknown),Timothy R. Carroll	10
9	Labeling Cyclic Glycoprotein IIb/IIIa Receptor Antagonists with ^99mTc by the Preformed Chelate Approach: Effects of Chelators on Properties of [^99mTc]Chelator−Peptide Conjugates 1996 ·Bioconjugate Chemistry ·Shuang Liu,David S. Edwards,Richard Looby,(unknown),Milind Rajopadhye,(unknown),Timothy R. Carroll	61
10	Tc-99m-labeled fibrinogen receptor antagonists: design and synthesis of cyclic RGD peptides for the detection of thrombi 1996 ·Bioorganic & Medicinal Chemistry Letters ·Thomas D. Harris,Milind Rajopadhye,(unknown),Danuta Głowacka,(unknown),(unknown),John Barrett,(unknown),Stuart J. Heminway,Joel Lazewatsky,(unknown),Timothy R. Carroll	15
11	Biological Evaluation of ^99mTc-Labeled Cyclic Glycoprotein IIb/IIIa Receptor Antagonists in the Canine Arteriovenous Shunt and Deep Vein Thrombosis Models: Effects of Chelators on Biological Properties of [^99mTc]Chelator−Peptide Conjugates 1996 ·Bioconjugate Chemistry ·John Barrett,(unknown),Stuart J. Heminway,Shuang Liu,David S. Edwards,Richard Looby,Timothy R. Carroll	45
12	Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice. 1995 ·PubMed ·Paul D. Crane,David Onthank,(unknown),Stuart J. Heminway,(unknown),Irwin Leav,(unknown),Joel Lazewatsky,(unknown),Timothy R. Carroll	14
13	Functional cholesteryl binding agents: Evaluation of viability and specificity of antibodies bound to modified phospholipid vesicles 1988 ·Biochemical and Biophysical Research Communications ·Timothy R. Carroll,Alan Davison,Alun G. Jones	1
14	Functional cholesteryl binding agents: synthesis, characterization, and evaluation of antibody binding to modified phospholipid vesicles 1986 ·Journal of Medicinal Chemistry ·Timothy R. Carroll,Alan Davison,Alun G. Jones	7
15	Reproductive success of Herring Gulls on Granite Island, northern Lake Superior, 1975 and 1976 1978 ·The Canadian Field-Naturalist ·John P. Ryder,Timothy R. Carroll	1

About Timothy R. Carroll

Timothy R. Carroll is a scholar working on Internal Medicine, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 433 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (363 citations), Immunology and Allergy (43 citations) and Oncology (184 citations). Timothy R. Carroll has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include David S. Edwards, Stuart J. Heminway, John Barrett, Richard Looby, Shuang Liu, Anthony R. Harris, Milind Rajopadhye, Shuang Liu, Joel Lazewatsky and Mikhail Kagan. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Bioconjugate Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact